cancer vaccine - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Coursera (NYSE: COUR) plunges 26% as Udemy savings accelerate. Where is the growth?

Trump administration loses Alaska Senate ballot case as judge rejects election delay

Whitehaven Coal’s A$1bn Winchester South project clears major court hurdle but approvals remain outstanding

Sun Pharmaceutical (SUNPHARMA) gains US approval for ILUMYA as Q2 profit falls 36%

OS Therapies eyes global approvals for OST-HER2 after breakthrough osteosarcoma vaccine trial

Read More

Healthcare Industry News

OS Therapies eyes global approvals for OST-HER2 after breakthrough osteosarcoma vaccine trial

OS Therapies’ OST-HER2 cancer vaccine shows strong survival gains in Phase IIb osteosarcoma trial—discover what comes next for global approval.

byPallavi Madhiraju

October 11, 2025

web analytics